InMode (InMode) Common Stock : $0.2 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is InMode Common Stock?

InMode's quarterly common stock stayed the same from Jun. 2023 ($0.0 Mil) to Sep. 2023 ($0.0 Mil) but then increased from Sep. 2023 ($0.0 Mil) to Dec. 2023 ($0.2 Mil).

InMode's annual common stock increased from Dec. 2021 ($0.2 Mil) to Dec. 2022 ($0.2 Mil) and increased from Dec. 2022 ($0.2 Mil) to Dec. 2023 ($0.2 Mil).

InMode Common Stock Historical Data

The historical data trend for InMode's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InMode Common Stock Chart

InMode Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

0.09

0.22

0.24

0.25

InMode Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															0.24	-	-	-	0.25

InMode Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

InMode (InMode) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InMode Ltd (NAS:INMD) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

154:Germany 154:Germany

Address

Tavor Building, Sha’ar Yokneam, P.O. Box 533, Yokneam, ISR, 2069206

Website

https://www.inmodemd.com

InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its products platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.